本报记者 朱萍 北京报道 复华药业虚开发票,在行业里已经是公开的秘密。随着“营改增”、“两票制”的实施,行业违规甚至违法的一些劣迹逐渐暴露。 9月13日,上海复旦复华科技股份有限公司(600624.SH)发布公告,其控股子公司上海复旦复华药业有限公司(下称复华药业)于2016年9...
Our reporter Zhu Ping Reporting from Beijing After China pharmaceutical falsely making out invoice, in the industry has been an open secret. Change increases as the "camp", "two votes", the implementation of the industry and even illegal violations gradually exposed some misdeeds. On September 13, Shanghai fudan after China science and technology co., LTD. (600624. SH) announced that its subsidiary Shanghai fudan after China pharmaceutical co., LTD. (hereinafter referred to as the complex China pharmaceutical) in 2016...